Brand-Name Competition for Diabetes Drugs Has Variable Impact on Net Prices
And, one in five generic drugs sold in U.S. experienced price spikes initiated by manufacturers during 2014 to 2017
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.